Summary
doi: 10.25005/2074-0581-2013-15-1-126-131
Modern antidepressants in clinical cardiology
Chair of Internal Medicine №2 Avicenna TSMU
In reviewing of literature the modern data on relationship of stress, anxiety and depression with cardiovascular disease are presented. Noted that anxiety and depressive disorders increased by 1.5-2 times the risk of developing cardiovascular disease and sudden cardiac death.
Pointed that new generation of antidepressants - selective serotonin reuptake inhibitors (SSRIs), and derivatives of melatonin have no side effects typical of tricyclic antidepressants and may be used to treat patients with cardiovascular disease comorbid depression. Also important that these drugs, in contrast to conventional antidepressant suitable for the treatment of comorbid anxiety and depressive disorders in patients with cardiovascular disease in older age groups.
Keywords: cardiovascular disease, comorbid depression , antidepressants.
Materials on the topic:
- Surgical treatment of idiopathik scared stenose of trachea
- Clinical - immunological disorders in urogenital chlamydiosis in men
- Evaluation of medication «Corvitin» in complex treatment of patients with acute myocardial infarction
- Prevalence of liver cirrhosis in Tajikistan
- Results of therapy patients in acute stage of HIV infection among prisoners
- Analysis of pregnant women morbidity, such as research microelement status of women's population living in districts of town Lipetsk with different atnropotehnogenic load
- Hormonal and metabolic concept of pathogenesis prostate diseases
- MEDICINES INFLUENCING ON REGENERATION OF PERIPHERIAL NERVES
- ABDOMINOPLASTICS IN PATIENTS WITH POSTOPERATING SCARS OF FRONT ABDOMENWALL
- PROCESS OF RECANALIZATION IN YEARLY PERIOD AFTER ACUTE TROMBOPHLEBITIS OF DEEP VEINS OF LOW EXTREMITIS